CN102441105A - Chinese herbal medicine for treating trachitis and asthma - Google Patents
Chinese herbal medicine for treating trachitis and asthma Download PDFInfo
- Publication number
- CN102441105A CN102441105A CN2011103976144A CN201110397614A CN102441105A CN 102441105 A CN102441105 A CN 102441105A CN 2011103976144 A CN2011103976144 A CN 2011103976144A CN 201110397614 A CN201110397614 A CN 201110397614A CN 102441105 A CN102441105 A CN 102441105A
- Authority
- CN
- China
- Prior art keywords
- parts
- asthma
- herbal medicine
- chinese herbal
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese herbal medicine for treating trachitis and asthma. Raw materials for the Chinese herbal medicine comprise, by weight, 20 to 40 parts of gecko, 18 to 38 parts of Radix Astragali, 12 to 25 parts of divaricate saposhnikovia root, 18 to 38 parts of lumbricus, 12 to 25 parts of ephedra stem, 12 to 25 parts of scorpion, 12 to 25 parts of Chinese magnoliavine, 12 to 25 parts of ginseng, 12 to 25 parts of liriope, 18 to 38 parts of epimeddium, 12 to 25 parts of rhizome pinelliae preparata, 18 to 38 parts of human placenta, 12 to 25 parts of licorice, 12 to 25 parts of gypsum, 12 to 25 parts of bitter apricot kernel, 18 to 38 parts of rhizoma drynariae and 12 to 25 parts of Chinese yam. The Chinese herbal medicine for treating trachitis and asthma in the invention is deliberately developed under the guidance of TCM theory, employs supporting and essence-solidifying treatment and focuses on regulation of lung, spleen and kidney. The medicine can benefit qi, secure the exterior, tonify qi, invigorate spleen, reinforce kidney and nourish yin, and has the advantages of a reasonable and scientific formula, a simple preparation method, easily controllable quality, a high cure rate, low recurrence and no toxic and side effects.
Description
Technical field
The present invention relates to a kind of Chinese medicine that is used to treat tracheitis, asthma.
Background technology
Bronchial asthma is a kind of serious chronic inflammatory airway disease; Usually bronchus causes the air flue myxedema because of allergic inflammation, and mucous secretion increases, and can cause that tracheal smooth muscle shrinks; Make airway narrows; Thereby air turnover pulmonary is hindered, and clinical manifestation causes respiratory failure even threat to life for symptoms such as the panting of outbreak repeatedly, tachypnea, uncomfortable in chest or coughs during serious attack.The conventional treatments of doctor trained in Western medicine is spasmolytic, antiinflammatory, eliminate the phlegm, the cough-relieving four processes, but poor effect be prone to recurrence after the drug withdrawal, and side effect is many, and untoward reaction is common.
Summary of the invention
The present invention is directed to the above-mentioned deficiency of existence aspect the treatment tracheitis, asthma at present, a kind of Chinese medicine that is used to treat tracheitis, asthma is provided.
The technical scheme that the present invention solves the problems of the technologies described above is following: a kind of raw material and parts by weight thereof that are used to treat the Chinese medicine of tracheitis, asthma comprise: 20～40 parts of Geckos; 18～38 parts of the Radixs Astragali; Windproof 12～25 parts; 18～38 parts of Pheretimas; 12～25 parts in Herba Ephedrae; 12～25 parts of Scorpios; 12～25 parts of Fructus Schisandrae Chinensis; 12～25 parts of Radix Ginsengs; 12～25 parts of Radix Ophiopogonis; 18～38 parts of Herba Epimedii; 12～25 parts of Rhizoma Pinelliae; 18～38 parts of Placenta Hominiss; 12～25 parts in Radix Glycyrrhizae; 12～25 parts in Gypsum Fibrosum; 12～25 parts of Semen Armeniacae Amarums; 12～25 parts of 18～38 parts of Rhizoma Drynariae and Rhizoma Dioscoreaes.
On the basis of technique scheme, the present invention can also do following improvement.
Further, the raw material of said Chinese medicine and parts by weight thereof comprise: 18～22 parts of 30～35 parts of Geckos, 28～33 parts of the Radixs Astragali, windproof 18～22 parts, 28～33 parts of Pheretimas, 18～22 parts in Herba Ephedrae, 18～22 parts of Scorpios, 18～22 parts of Fructus Schisandrae Chinensis, 18～22 parts of Radix Ginsengs, 18～22 parts of Radix Ophiopogonis, 28～33 parts of Herba Epimedii, 18～22 parts of Rhizoma Pinelliae, 28～33 parts of Placenta Hominiss, 18～22 parts in Radix Glycyrrhizae, 18～22 parts in Gypsum Fibrosum, 18～22 parts of Semen Armeniacae Amarums, 28～33 parts of Rhizoma Drynariae and Rhizoma Dioscoreaes.
Further, the raw material of said Chinese medicine and parts by weight thereof comprise: 20 parts of 32 parts of Geckos, 30 parts of the Radixs Astragali, windproof 20 parts, 30 parts of Pheretimas, 20 parts in Herba Ephedrae, 20 parts of Scorpios, 20 parts of Fructus Schisandrae Chinensis, 20 parts of Radix Ginsengs, 20 parts of Radix Ophiopogonis, 30 parts of Herba Epimedii, 20 parts of Rhizoma Pinelliae, 30 parts of Placenta Hominiss, 20 parts in Radix Glycyrrhizae, 20 parts in Gypsum Fibrosum, 20 parts of Semen Armeniacae Amarums, 30 parts of Rhizoma Drynariae and Rhizoma Dioscoreaes.
The invention has the beneficial effects as follows: the Chinese medicine that the present invention is used to treat tracheitis, asthma is under instruction of Chinese Medicine theory, and concentrating on studies forms, and adopts " element culturing fixed folder " method, focuses on to transfer tonifying the lung, spleen, kidney.Benefiting QI for strengthening the superficies, replenishing QI to invigorate the spleen, replenishing kidney-YIN, fill a prescription reasonable, science, method for preparing is simple, and control of quality, and cure rate easily is high, difficult to be recurred, has no side effect.
The specific embodiment
Below principle of the present invention and characteristic are described, institute gives an actual example and only is used to explain the present invention, is not to be used to limit scope of the present invention.
Bronchial asthma is a kind of serious chronic inflammatory airway disease, and bronchus causes the air flue myxedema because of allergic inflammation usually, and mucous secretion increases, and can cause that tracheal smooth muscle shrinks, and makes airway narrows.Thereby air turnover pulmonary is hindered, and clinical manifestation causes respiratory failure even threat to life for symptoms such as the panting of outbreak repeatedly, tachypnea, uncomfortable in chest or coughs during serious attack.Bronchial asthma has become a global serious health problem, and global conservative estimation has the bronchial asthma patient at least more than 100,000,000 5 thousand ten thousand.The traditional Chinese medical science thinks that bronchial asthma is because of lung, spleen, kidney three dirty insufficiency of function, water wet cohesion be phlegm retention, chance exopathogen priming and send out phlegm rising following QI; Obstruction of QI due to retention of phlegm, the knot of fighting each other hinders in air flue, impaired depurative descending of lung QI and the cough with asthma rale occurs; Very then can not put down for sleeping in, uncomfortable in chest, the not well disease of waiting of coughing up phlegm.Primary disease has that new disease is many real, how empty prolonged illness is, the domination of pathogen when sending out, weakened body resistance characteristics at ordinary times.To this sick mechanism, " the stilbene clam only roar capsule " of the research and development of my institute is in the effect that can play better controlled and delay to recur aspect the bronchial wheezing of pattern of syndrome such as treatment asthma of heat type, anemophlegmatic asthma, empty heavy breathing.The merit that its epheday intermedia, Gecko, Pheretima, Semen Armeniacae Amarum, Rhizoma Pinelliae have qi boosting calm panting, relieving cough and resolving phlegm is monarch drug altogether; The merit that Radix Ginseng, the Radix Astragali, Rhizoma Dioscoreae, Placenta Hominis, Herba Epimedii, Rhizoma Drynariae have the monarch's of helping tonify deficiency helping inspiration to relieve asthma is ministerial drug altogether; Gypsum Fibrosum, Radix Ophiopogonis, Fructus Schisandrae Chinensis, Scorpio, windproof merit with expelling wind and clearing away heat lung moistening are adjuvant drug altogether; The Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription is a messenger drug.More than all medicines play jointly tonify Qi of the kidney, the merit of removing heat-phlegm, relieving cough and asthma.
Clinical report:
1, physical data:
1 data and method
1.1 physical data:
200 examples are Xianghe County asthma section of tracheitis, asthma hospital inpatient, adopt the randomized, double-blind principle to be divided into 2 groups.100 examples are organized in treatment, male 54 examples, women 46 examples; 18～64 years old age, average (42.2 ± 8.4) year; The course of disease 4.2～28 years, average (8.4 ± 4.6) year.Matched group 100 examples, male 52 examples, women 48 examples; 19～65 years old age, average (41.1 ± 9.2) year; The course of disease 4.8～26 years, average (8.6 ± 4.3) year.2 groups of physical data comparing difference not statistically significants (P＞0.05) have comparability.
2 diagnostic criterias:
Western medicine diagnose with reference to " prevention and control of bronchial asthma guide " tcm diagnosis in 2008 and differentiation of symptoms and signs for classification of syndrome with reference to State Administration of Traditional Chinese Medicine " traditional Chinese medical science disease diagnosis criterion of therapeutical effect ".
2.1 the standard of including in:
Meet the diagnosis diagnosis; 18 years old～65 years old age; The course of disease was in 4～30 years; Inpatient; I know the inside story
2.2 observation index:
With reference to the symptom scalar quantization standard of listing in " new Chinese medicine clinical research guideline " [4] in 2002; In conjunction with every of being seen symptom in clinical (cough, expectoration, laryngeal stridor, breathe heavily and suppress) by light, in, 2 minutes heavily respectively, 4 minutes, 6 minutes; Every of inferior disease (appetite, bitter taste, constipation, breathe hard) was by in light 1 minute heavily respectively, 3 minutes, 5 minutes; Before and after the treatment item by item inquiry observe, calculate also record total mark, observed and recorded picture of the tongue, pulse condition but do not score.
2.3 criterion of therapeutical effect:
With reference to the therapeutic effect of syndrome criterion in " new Chinese medicine clinical research guideline ".Produce effects: original symptom complete obiteration or significantly alleviate, symptom integral reduces >=70%; Effectively: original symptom takes a turn for the better to some extent or alleviates, symptom integral reduce >=30% but＜70%; Invalid: original symptom does not have improvement, and symptom integral reduces＜30%.
3 results:
Two groups of Comparison of therapeutic
The result shows: the result shows: produce effects 76 examples, effective 15 examples, invalid 9 examples, total effective rate 91.0%.
4, model case:
Embodiment 1:
Above-mentioned raw materials is prepared into hard capsule by " the preparation quality standard JZBZ20090676 of medical institutions of Hebei province's food and medicine Surveillance Authority " prescriptive procedure, uses after the assay was approved.
Lee so-and-so, woman, 32 years old, people from Bozhou, Anhui Province.Suffer from bronchial asthma companion cough, expectoration, breathe heavily and suppress 30 years, increased the weight of 1 year.Through the doctor trained in Western medicine conventional therapy, poor effect comes my institute to be in hospital, and takes 6 of the hard capsules that embodiment 1 processes at every turn; Every day 3 times, to take continuously 180 days, the two pulmonary respiration changes of tune in treatment back are thick, and the trusted subordinate is negative; Edema of pair of lower extremities disappears, and vital capacity is by 500ml value added 1300ml, and transference cure does not recur.
Week so-and-so, the man, 35 years old, people from Qidong County, Hunan Province suffered from bronchial asthma, outbreak is repeatedly panted, feels suffocated surplus in the of 10 year.Through the doctor trained in Western medicine conventional therapy, poor effect comes my institute to be in hospital, and takes 6 of the hard capsules that embodiment 1 processes at every turn; Every day 3 times, to take continuously 120 days, the two pulmonary respiration sounds in treatment back are clear; Dried moist rales disappears, and the trusted subordinate is negative, two lower limb pneumonedema; Vital capacity increases to 2700ml by 2100ml, transference cure, not recurrence.
Embodiment 2:
Above-mentioned raw materials is prepared into hard capsule by " the preparation quality standard JZBZ20090676 of medical institutions of Hebei province's food and medicine Surveillance Authority " prescriptive procedure, uses after the assay was approved.
Gong so-and-so, the man, 11 years old, people from Liaoning Province suffered from surplus the bronchial asthma 2 year, through the doctor trained in Western medicine conventional therapy, poor effect comes me institute to be in hospital, and takes 4 of the hard capsules that embodiment 2 processes at every turn, takes continuously 120 days every day 3 times, fully recovers after treat two courses of treatment, recurs.
Embodiment 3:
Above-mentioned raw materials is prepared into hard capsule by " the preparation quality standard JZBZ20090676 of medical institutions of Hebei province's food and medicine Surveillance Authority " prescriptive procedure, uses after the assay was approved.
Liu so-and-so, the woman, 55 years old, suffer from surplus the bronchial asthma 30 year, once at local hospital western medical treatment, poor effect comes me institute to be in hospital, and takes 6 of the hard capsules that embodiment 3 processes at every turn, takes continuously 150 days every day 3 times, fully recovers after treat two courses of treatment, recurs.
Embodiment 4:
Above-mentioned raw materials is prepared into hard capsule by " the preparation quality standard JZBZ20090676 of medical institutions of Hebei province's food and medicine Surveillance Authority " prescriptive procedure, uses after the assay was approved.
The land so-and-so, the woman, 58 years old, suffer from surplus the bronchial asthma 50 year, through doctor trained in Western medicine conventional therapy poor effect, come me institute to be in hospital, take 6 of the hard capsules that embodiment 4 processes at every turn, took continuously 180 days every day 3 times, fully recover after treat a course of treatment, recur.
The above is merely preferred embodiment of the present invention, and is in order to restriction the present invention, not all within spirit of the present invention and principle, any modification of being done, is equal to replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (3)
1. Chinese medicine that is used to treat tracheitis, asthma; It is characterized in that its raw material and parts by weight thereof comprise: 12～25 parts of 20～40 parts of Geckos, 18～38 parts of the Radixs Astragali, windproof 12～25 parts, 18～38 parts of Pheretimas, 12～25 parts in Herba Ephedrae, 12～25 parts of Scorpios, 12～25 parts of Fructus Schisandrae Chinensis, 12～25 parts of Radix Ginsengs, 12～25 parts of Radix Ophiopogonis, 18～38 parts of Herba Epimedii, 12～25 parts of Rhizoma Pinelliae, 18～38 parts of Placenta Hominiss, 12～25 parts in Radix Glycyrrhizae, 12～25 parts in Gypsum Fibrosum, 12～25 parts of Semen Armeniacae Amarums, 18～38 parts of Rhizoma Drynariae and Rhizoma Dioscoreaes.
2. the Chinese medicine that is used to treat tracheitis, asthma according to claim 1; It is characterized in that its raw material and parts by weight thereof comprise: 18～22 parts of 30～35 parts of Geckos, 28～33 parts of the Radixs Astragali, windproof 18～22 parts, 28～33 parts of Pheretimas, 18～22 parts in Herba Ephedrae, 18～22 parts of Scorpios, 18～22 parts of Fructus Schisandrae Chinensis, 18～22 parts of Radix Ginsengs, 18～22 parts of Radix Ophiopogonis, 28～33 parts of Herba Epimedii, 18～22 parts of Rhizoma Pinelliae, 28～33 parts of Placenta Hominiss, 18～22 parts in Radix Glycyrrhizae, 18～22 parts in Gypsum Fibrosum, 18～22 parts of Semen Armeniacae Amarums, 28～33 parts of Rhizoma Drynariae and Rhizoma Dioscoreaes.
3. the Chinese medicine that is used to treat tracheitis, asthma according to claim 1; It is characterized in that its raw material and parts by weight thereof comprise: 20 parts of 32 parts of Geckos, 30 parts of the Radixs Astragali, windproof 20 parts, 30 parts of Pheretimas, 20 parts in Herba Ephedrae, 20 parts of Scorpios, 20 parts of Fructus Schisandrae Chinensis, 20 parts of Radix Ginsengs, 20 parts of Radix Ophiopogonis, 30 parts of Herba Epimedii, 20 parts of Rhizoma Pinelliae, 30 parts of Placenta Hominiss, 20 parts in Radix Glycyrrhizae, 20 parts in Gypsum Fibrosum, 20 parts of Semen Armeniacae Amarums, 30 parts of Rhizoma Drynariae and Rhizoma Dioscoreaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103976144A CN102441105A (en) | 2011-12-02 | 2011-12-02 | Chinese herbal medicine for treating trachitis and asthma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103976144A CN102441105A (en) | 2011-12-02 | 2011-12-02 | Chinese herbal medicine for treating trachitis and asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102441105A true CN102441105A (en) | 2012-05-09 |
Family
ID=46004365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011103976144A Pending CN102441105A (en) | 2011-12-02 | 2011-12-02 | Chinese herbal medicine for treating trachitis and asthma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102441105A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103127255A (en) * | 2013-03-06 | 2013-06-05 | 陈霞 | Antioxidant externally-applied Chinese medicine dressing formula for treating asthma and preparation method thereof |
| CN103505707A (en) * | 2013-09-22 | 2014-01-15 | 广东省中医院 | Traditional Chinese medicinal preparation for treating asthma and preparation method of traditional Chinese medicinal preparation |
| CN106266536A (en) * | 2016-08-23 | 2017-01-04 | 香河县气管炎哮喘医院 | A kind of Chinese medicinal capsule treating tracheitis, asthma and preparation method thereof |
| CN109893645A (en) * | 2018-11-21 | 2019-06-18 | 杨启祥 | A kind of drug of combination of Chinese tradiational and Western medicine acupoint therapy tracheitis, asthma |
| CN115006507A (en) * | 2022-05-23 | 2022-09-06 | 山东医学高等专科学校 | Traditional Chinese medicine composition for treating respiratory diseases and preparation method and application thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1310002A (en) * | 2001-02-19 | 2001-08-29 | 孟庆云 | Combined Chinese and Western medicine for treating bronchial asthma |
-
2011
- 2011-12-02 CN CN2011103976144A patent/CN102441105A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1310002A (en) * | 2001-02-19 | 2001-08-29 | 孟庆云 | Combined Chinese and Western medicine for treating bronchial asthma |
Non-Patent Citations (3)
| Title |
|---|
| 吴平路 等: "《孟庆云治疗支气管哮喘经验总结》", 《中国中医药信息杂志》 * |
| 张传名: "《中医药治疗支气管哮喘进展》", 《江西中医药》 * |
| 汤翠英，许银姬: "《支气管哮喘证治研究进展》", 《现代中西医结合杂志》 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103127255A (en) * | 2013-03-06 | 2013-06-05 | 陈霞 | Antioxidant externally-applied Chinese medicine dressing formula for treating asthma and preparation method thereof |
| CN103127255B (en) * | 2013-03-06 | 2014-12-24 | 陈霞 | Antioxidant externally-applied Chinese medicine dressing formula for treating asthma and preparation method thereof |
| CN103505707A (en) * | 2013-09-22 | 2014-01-15 | 广东省中医院 | Traditional Chinese medicinal preparation for treating asthma and preparation method of traditional Chinese medicinal preparation |
| CN103505707B (en) * | 2013-09-22 | 2015-07-15 | 广东省中医院 | Traditional Chinese medicinal preparation for treating asthma and preparation method of traditional Chinese medicinal preparation |
| CN106266536A (en) * | 2016-08-23 | 2017-01-04 | 香河县气管炎哮喘医院 | A kind of Chinese medicinal capsule treating tracheitis, asthma and preparation method thereof |
| CN106266536B (en) * | 2016-08-23 | 2017-10-31 | 香河县气管炎哮喘医院 | It is a kind of to treat Chinese medicinal capsule of tracheitis, asthma and preparation method thereof |
| CN109893645A (en) * | 2018-11-21 | 2019-06-18 | 杨启祥 | A kind of drug of combination of Chinese tradiational and Western medicine acupoint therapy tracheitis, asthma |
| CN115006507A (en) * | 2022-05-23 | 2022-09-06 | 山东医学高等专科学校 | Traditional Chinese medicine composition for treating respiratory diseases and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102441129B (en) | Traditional Chinese medicine for treating chronic pulmonary heart disease | |
| CN101143176A (en) | Traditional Chinese medicine for treating pneumonia | |
| CN102441105A (en) | Chinese herbal medicine for treating trachitis and asthma | |
| CN102416129A (en) | Chinese medicine for treating paracmastic chronic obstructive pulmonary disease | |
| CN101129667A (en) | Traditional Chinese medicine for treating bronchial asthma | |
| CN103784638A (en) | Traditional Chinese medicine decoction used for preventing and treating children heat asthma | |
| CN101138613A (en) | Traditional Chinese medicine for treating acute bronchitis of children | |
| CN102416096B (en) | Traditional Chinese medicine for treating bronchiectasis | |
| CN103142857B (en) | Chinese medicinal granules for treating bronchitis combined emphysema and preparation method thereof | |
| CN102526236B (en) | Pharmaceutical formulation for treating influenza and preparation method thereof | |
| CN108079173A (en) | A kind of medicament of pediatric asthma rehabilitation auxiliary | |
| CN106266542A (en) | A kind of Chinese medicine formula treating cough | |
| CN104027760A (en) | Traditional Chinese medicament for treating wind-phlegm in lung type asthma | |
| CN103272130B (en) | Preparation method of traditional Chinese medicine for treating chronic nasosinusitis by machine | |
| CN104147334A (en) | Traditional Chinese medicine formula capable of eliminating phlegm | |
| CN104173737A (en) | Traditional Chinese medicine formula for treating pulmonary interstitial fibrosis | |
| CN106729097A (en) | A kind of Chinese medicine composition for treating wind-warm lung-heat | |
| CN101143194A (en) | Traditional Chinese medicine for treating interstitial pneumonia | |
| CN102406747A (en) | Chinese medicinal composition for treating infant upper respiratory tract infection | |
| CN101181503B (en) | Chinese medicine prescription orally taken for curing chronic bronchitis | |
| CN101129856A (en) | Traditional Chinese medicine for treating lobar pneumonia | |
| CN107296889A (en) | It is a kind of effectively to treat decoction medicine of cough and preparation method thereof | |
| CN106309769A (en) | Traditional Chinese medicine composition for treating influenza type A | |
| CN104491790A (en) | Traditional Chinese medicine for treating chronic pharyngitis | |
| CN103585494A (en) | Traditional Chinese medicine composition for treating tuberculous meningitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120509 |